A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract

NCT04539548 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Dextenza Ophthalmic Insert
DRUG: Prednisolone acetate ophthalmic suspension USP 1%

Sponsor

Ocular Therapeutix, Inc.